Cite
HARVARD Citation
Jurczak, W. et al. (2021). Phase I, first-in-human trial of Bruton's tyrosine kinase inhibitor M7583 in patients with B-cell malignancies. Leukemia & lymphoma. 62 (10), pp. 2392-2399. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Jurczak, W. et al. (2021). Phase I, first-in-human trial of Bruton's tyrosine kinase inhibitor M7583 in patients with B-cell malignancies. Leukemia & lymphoma. 62 (10), pp. 2392-2399. [Online].